SCHEMBL3033723

SCHEMBL3033723

O=C(O)c1ccc2c(c1)CC1CCC(C2)C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
TDP1 Q9NUW8 2/20 0.44
SRD5A2 P31213 4/20 0.44
TDP2 O95551 1/20 0.41
SRD5A1 P18405 3/20 0.40
KDM4E B2RXH2 5/20 0.40
MAPT P10636 4/20 0.40
POLB P06746 3/20 0.40
BLM P54132 1/20 0.40
GRM1 Q13255 1/20 0.40
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM1A O60341 2/20 0.39
KMO O15229 1/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3028797 1.00 ALDH1A1 (0.49) ALDH1A1TDP1SRD5A2TDP2SRD5A1
SCHEMBL14263744 0.81 CHRNB2 (0.47) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL4045891 0.81 CHRNB2 (0.47) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL7165102 0.77 ALDH1A1 (0.50) ALDH1A1TDP1SRD5A2TDP2SRD5A1
SCHEMBL19718187 0.77 ALDH1A1 (0.53) ALDH1A1TDP1SRD5A2TDP2SRD5A1
SCHEMBL1025843 0.77 DRD2 (0.49) CA1CA2
SCHEMBL13866811 0.77 DRD2 (0.49) CA1CA2
SCHEMBL24214088 0.76 ALDH1A1 (0.49) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
Hydrochloric Acid SCHEMBL6642375 0.75 ALDH1A1 (0.52) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL15443897 0.75 ALDH1A1 (0.47) ALDH1A1TDP1SRD5A2TDP2SRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759492-B2 Enantioselective synthesis of 13-oxotricyclo[8.2.1.0.3,8] trideca-3(8),4,6-triene-5-carboxylates MERCK SHARP & DOHME LIMITED (GB) 2010-07-20 US disclosed
US-7759492-B2 Enantioselective synthesis of 13-oxotricyclo[8.2.1.0.3,8] trideca-3(8),4,6-triene-5-carboxylates MERCK SHARP & DOHME LIMITED (GB) 2010-07-20 US disclosed
US-20070244329-A1 Enantioselective Synthesis of 13-Oxotricyclo[8.2.1.0. 3,8] Trideca-3(8),4,6-Triene-5-Carboxylates MERCK SHARP & DOHME LIMITED (GB) 2007-10-18 US disclosed
CN-101006043-A Enantioselective synthesis of 13-oxotricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene-5-carboxylates MERCK SHARP & DOHME (GB) 2007-07-25 CN disclosed
EP-1781591-A1 ENANTIOSELECTIVE SYNTHESIS OF 13-OXOTRICYCLO[8.2.1.0 3,8]TRIDECA-3(8),4,6-TRIENE-5-CARBOXYLATES MERCK SHARP & DOHME LTD. (GB) 2007-05-09 EP disclosed
WO-2006018663-A1 ENANTIOSELECTIVE SYNTHESIS OF 13-OXOTRICYCLO[8.2.1.0 3,8]TRIDECA-3(8),4,6-TRIENE-5-CARBOXYLATES MERCK SHARP & DOHME LIMITED (GB) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244329-A1 Enantioselective Synthesis of 13-Oxotricyclo[8.2.1.0. 3,8] Trideca-3(8),4,6-Triene-5-Carboxylates CYP8B1, OXER1, CYP2A13 ALDH1A1 258/4885TDP1 191/4885SRD5A2 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.